Table 1.

Price of sevelamer hydrochloride and calcium-containing phosphate binders: 2001 to 2009^a

Medication				Price Measure ($)	Year (as of July 1 of Each Year)
Brand Name	Generic Name	Strength	Manufacturer		2001	2002	2003	2004	2005	2006	2007	2008	2009
Renagel	Sevelamer	800 mg	Genzyme	AWP	1.16	1.23	1.37	1.48	1.55	1.69	2.13	2.13	2.66
				WAC	NP	NP	1.10	1.18	1.24	1.35	1.71	1.71	2.13
TUMS	Calcium carbonate	500 mg	GlaxoSmithKline	AWP	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
				WAC	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
TUMS Ultra	Calcium carbonate	1000 mg	GlaxoSmithKline	AWP	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
				WAC	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
PhosLo	Calcium acetate	667 mg	Braintree Laboratories, Fresenius Medical Care	AWP	0.15	0.15	0.19	0.21	0.34	0.34	0.47	0.88	0.88
				WAC	0.12	0.12	0.15	NP	0.27	0.27	0.38	0.70	0.70
Generic	Calcium acetate	667 mg	Roxane	AWP	NM	NM	NM	NM	NM	NM	NM	NMb	0.79
				WAC	NM	NM	NM	NM	NM	NM	NM	NMb	NP
Eliphos	Calcium acetate	667 mg	Cypress (Hawthorn)	AWP	NM	NM	NM	NM	NM	NM	NM	NMc	0.56
				WAC	NM	NM	NM	NM	NM	NM	NM	NMc	0.45

NP, product was on the market but the price was not published in MediSpan's PriceChek PC; NM, product was not on the market.

^aPrice as of July 1 in the year indicated. Data are from MediSpan's PriceChek PC (Indianapolis, IN: Wolters Kluwer Health, 2009) and are based on archived and current data as of July 1, 2009.

^bGeneric calcium acetate capsules from Roxane received U.S. Food and Drug Administration approval on February 26, 2008.

^cCalcium acetate tablets (Eliphos) from Hawthorn (a division of Cypress) received U.S. Food and Drug Administration approval on November 24, 2008.